184 related articles for article (PubMed ID: 37261631)
21. The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials.
Pizer BL; Clifford SC
Br J Neurosurg; 2009 Aug; 23(4):364-75. PubMed ID: 19637007
[TBL] [Abstract][Full Text] [Related]
22. Current studies and future directions for medulloblastoma: A review from the pacific pediatric neuro-oncology consortium (PNOC) disease working group.
Cooney T; Lindsay H; Leary S; Wechsler-Reya R
Neoplasia; 2023 Jan; 35():100861. PubMed ID: 36516489
[TBL] [Abstract][Full Text] [Related]
23. Medulloblastoma-biology and microenvironment: a review.
Byrd T; Grossman RG; Ahmed N
Pediatr Hematol Oncol; 2012 Sep; 29(6):495-506. PubMed ID: 22742590
[TBL] [Abstract][Full Text] [Related]
24. SnapShot: Medulloblastoma.
Rusert JM; Wu X; Eberhart CG; Taylor MD; Wechsler-Reya RJ
Cancer Cell; 2014 Dec; 26(6):940-940.e1. PubMed ID: 25490452
[TBL] [Abstract][Full Text] [Related]
25. New Approaches in Targeted Therapy for Medulloblastoma in Children.
Maier H; Dalianis T; Kostopoulou ON
Anticancer Res; 2021 Apr; 41(4):1715-1726. PubMed ID: 33813375
[TBL] [Abstract][Full Text] [Related]
26. Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.
von Bueren AO; von Hoff K; Pietsch T; Gerber NU; Warmuth-Metz M; Deinlein F; Zwiener I; Faldum A; Fleischhack G; Benesch M; Krauss J; Kuehl J; Kortmann RD; Rutkowski S
Neuro Oncol; 2011 Jun; 13(6):669-79. PubMed ID: 21636711
[TBL] [Abstract][Full Text] [Related]
27. Management of and prognosis with medulloblastoma: therapy at a crossroads.
Packer RJ; Vezina G
Arch Neurol; 2008 Nov; 65(11):1419-24. PubMed ID: 19001159
[TBL] [Abstract][Full Text] [Related]
28. Treatment controversies in medulloblastoma.
Chintagumpala M; Berg S; Blaney SM
Curr Opin Oncol; 2001 May; 13(3):154-9. PubMed ID: 11307057
[TBL] [Abstract][Full Text] [Related]
29. Current treatment of medulloblastoma: recent advances and future challenges.
Rood BR; Macdonald TJ; Packer RJ
Semin Oncol; 2004 Oct; 31(5):666-75. PubMed ID: 15497120
[TBL] [Abstract][Full Text] [Related]
30. Pathology, diagnostics, and classification of medulloblastoma.
Orr BA
Brain Pathol; 2020 May; 30(3):664-678. PubMed ID: 32239782
[TBL] [Abstract][Full Text] [Related]
31. 12-year-old boy with multiple brain masses.
Massimi L; Caldarelli M; D'Alessandris QG; Rollo M; Lauriola L; Giangaspero F; Di Rocco C
Brain Pathol; 2010 May; 20(3):679-82. PubMed ID: 20522094
[TBL] [Abstract][Full Text] [Related]
32. LIN28 expression and function in medulloblastoma.
Maklad A; Sedeeq M; Wilson R; Heath JA; Gueven N; Azimi I
J Cell Physiol; 2023 Mar; 238(3):533-548. PubMed ID: 36649308
[TBL] [Abstract][Full Text] [Related]
33. Medulloblastoma with extensive nodularity: a report of two cases.
Hellbusch LC; Robinson MN; McComb RD; Gordon BG; Meyer RC
Pediatr Neurosurg; 2008; 44(5):430-2. PubMed ID: 18703894
[No Abstract] [Full Text] [Related]
34. Metastatic medulloblastoma at diagnosis.
Gupta S; Pant MC; Husain N; Sundar S
J Cancer Res Ther; 2011; 7(2):203-4. PubMed ID: 21768715
[TBL] [Abstract][Full Text] [Related]
35. Urinary protein biomarkers for pediatric medulloblastoma.
Hao X; Guo Z; Sun H; Liu X; Zhang Y; Zhang L; Sun W; Tian Y
J Proteomics; 2020 Aug; 225():103832. PubMed ID: 32474013
[TBL] [Abstract][Full Text] [Related]
36. Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.
Hill RM; Richardson S; Schwalbe EC; Hicks D; Lindsey JC; Crosier S; Rafiee G; Grabovska Y; Wharton SB; Jacques TS; Michalski A; Joshi A; Pizer B; Williamson D; Bailey S; Clifford SC
Lancet Child Adolesc Health; 2020 Dec; 4(12):865-874. PubMed ID: 33222802
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging spectrum of medulloblastoma.
Fruehwald-Pallamar J; Puchner SB; Rossi A; Garre ML; Cama A; Koelblinger C; Osborn AG; Thurnher MM
Neuroradiology; 2011 Jun; 53(6):387-96. PubMed ID: 21279509
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis.
Zhao F; Zhang J; Li P; Zhou Q; Zhang S; Zhao C; Wang B; Yang Z; Li C; Liu P
J Neurooncol; 2018 Sep; 139(2):333-340. PubMed ID: 29687281
[TBL] [Abstract][Full Text] [Related]
39. [Medulloblastoma in adults].
Hopf-Jensen S; Buchalla R; Preiß M; Feist H; Börm W; Müller-Hülsbeck S
Rofo; 2014 Sep; 186(9):825-8. PubMed ID: 25171381
[No Abstract] [Full Text] [Related]
40. Management of pediatric and adult patients with medulloblastoma.
Martin AM; Raabe E; Eberhart C; Cohen KJ
Curr Treat Options Oncol; 2014 Dec; 15(4):581-94. PubMed ID: 25194927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
